Fco. Javier Muñoz Gall Institutions of which they are part Main researcher Pneumology Vall Hebron Institut de Recerca Email Fco. Javier Muñoz Gall Email Institutions of which they are part Main researcher Pneumology Vall Hebron Institut de Recerca
Research lines Work-related diseases, asthma and fibrosis. The Group is considered a referral team for the diagnosis and treatment of work-related lung diseases in Catalonia, centring mainly on occupational asthma, hypersensitivity pneumonitis, and occupational disease caused by asbestos exposure. It is responsible for the creation and monitoring of the Spanish Registry of Occupational Diseases (EROL), an important task that had not been covered previously. The Group forms a part of the Grup Col.laboratiu per la Investigació de l’Asma per Soja a Barcelona (Collaborative Research Group for Soy Asthma in Barcelona). Moreover, it is an officially accredited center to carry out daily determinations of environmental levels of soy aeroallergens in Barcelona. For this purpose, the Group has an agreement with the Servicio de Medio Ambiente del Puerto de Barcelona (Environmental Service of the Port of Barcelona), which uses the results of these analyses to monitor the unloading of soy products in the city’s port. This daily monitoring of soy aeroallergen in the city has helped the authorities been to eliminate further asthma epidemics The Group has been given several awards for its work in the area of soy asthma, such as the Fundació Cor Vilacasas award (1993), the Science Award of the City of Barcelona (1995), and the Josep Trueta Award from the Acadèmia de Ciències Mèdiques (1995). The team also has broad experience in the study of hypersensitivity pneumonitis, with a series of 150 patients that is one of the largest in the country, given the low prevalence of this condition. In addition, our center is considered a national referral hospital for the diagnosis and treatment of this pathology. Within the research into occupational disease due to asbestos exposure, our research laboratory is the only one in Spain that carries out determinations of asbestos bodies in the lung. IP: Fco. Javier Muñoz Gall Projects Efectos de la exposición a microplásticos en individuos asmáticos: respuesta inmunológica y mecanismos inflamatorios. IP: Fco. Javier Muñoz Gall Collaborators: David Espejo Castellanos, David Soler Segovia Funding agency: Instituto de Salud Carlos III Funding: 121250 Reference: PI24/00762 Duration: 01/01/2025 - 31/12/2027 EXPOSIM: Environmental stressors as causal determinants for immune-mediated diseases – mapping and prioritising evidence for knowledge-based policy making IP: Mª Jesús Cruz Carmona Collaborators: Fco. Javier Muñoz Gall, Antía Ferreiro Posse, David Soler Segovia Funding agency: EUROPEAN COMMISSION Funding: 521450 Reference: EC/HLTH-2024-ENVHLTH-02-06/2023/CARMONA Duration: 01/01/2025 - 31/12/2029 Grup de Recerca en Pneumologia IP: Jaume Ferrer Sancho Collaborators: Sergi Martí Beltran, Marta Vicenta Arjona Perís, Christian Eduardo Romero Mesones, Maria Angeles Jiménez Fuentes, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Álvarez Fernandez, Victor Monforte Torres, Odile Romero Santo-Tomas, Miriam Barrecheguren Fernández, David Clofent Alarcón, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Almudena Felipe Montiel, Eva Maria Revilla Lopez, Gerard Orriols Torras, Julia Sampol Sirvent, Meritxell Boada Perez, David Espejo Castellanos, Manuel López Meseguer, David Soler Segovia, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 00788 Duration: 01/01/2022 - 30/06/2025 Caracterización y factores de riesgo de las SEcuelas PULmonares de los pacientes que superan una neumonía por COVID-19 (PULSE-COVID). IP: Fco. Javier Muñoz Gall Collaborators: Maria Angeles Jiménez Fuentes, Marc Miravitlles Fernández, David Clofent Alarcón, David Soler Segovia Funding agency: Instituto de Salud Carlos III Funding: 135520 Reference: PI21/01046 Duration: 01/01/2022 - 31/12/2025 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 … Next page › Last page »
